United States · Series A startup

Who invested in Mirimus

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$2.0Mraised across 1 round since 2011, from 1 source

Latest round
Series A, $2.0MMar 2011
Investors
0
See who backed them

The rounds

  1. Mar 2011
    Series A$2.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $2.0M sold, first sale Feb 2011

Funding filed with regulators

Mirimus filed 2 raises, $2.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Feb 2011$2.0M2 investorsequitySEC Form D
  2. Jan 2011$8256 investorsequitySEC Form D

Founders and team

From Mirimus's own website and the SEC filings it signed: 3 on the team.

  • David EadsChief Financial Officer
  • Veronica AndrewsChief Operations Officer
  • Prem PremsrirutExecutive Officer, Directori

On the board, as filediJohn MaroneyLeo GuthartSteven Winick

Quick answers about Mirimus

How much has Mirimus raised?

Mirimus has raised $2.0M across 1 round since 2011.

When did Mirimus last raise?

Mirimus's most recent round was a Series A of $2.0M in Mar 2011.

What was Mirimus's biggest round?

Its most recent round, $2.0M in Mar 2011, is also its largest on record.

What stage is Mirimus at?

Mirimus's latest named round is a Series A, in Mar 2011.

Where is Mirimus based?

Mirimus is based in the United States.

Companies like Mirimus

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.